[
  {
    "ts": null,
    "headline": "Amgen: A Defensive Biotech With Yield And Optionality",
    "summary": "Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=d29511ee5ce710468af79d34306d9aaebd30df8f2334a15597d8e36aff9234a9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752082199,
      "headline": "Amgen: A Defensive Biotech With Yield And Optionality",
      "id": 135838482,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/169999232/image_169999232.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=d29511ee5ce710468af79d34306d9aaebd30df8f2334a15597d8e36aff9234a9"
    }
  },
  {
    "ts": null,
    "headline": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=e90209b6bc794d6b7f78da08d217fced2f826ef74943ede267b0286941e912ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752069002,
      "headline": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
      "id": 135835932,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=e90209b6bc794d6b7f78da08d217fced2f826ef74943ede267b0286941e912ed"
    }
  },
  {
    "ts": null,
    "headline": "Rethinking Prior Art Provisional Priority: The Federal Circuit's Disclosure-Level Test In In Re Riggs",
    "summary": "A published application must show written description support for both its claims and the specific subject matter relied upon as prior art, under a clarified standard for provisional priority. Reining...",
    "url": "https://finnhub.io/api/news?id=6a40c5e208c20e26b1b45ae3fdc73ac11e3dc4df02a83a4e721297aa0756acb6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752055928,
      "headline": "Rethinking Prior Art Provisional Priority: The Federal Circuit's Disclosure-Level Test In In Re Riggs",
      "id": 135834218,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "A published application must show written description support for both its claims and the specific subject matter relied upon as prior art, under a clarified standard for provisional priority. Reining...",
      "url": "https://finnhub.io/api/news?id=6a40c5e208c20e26b1b45ae3fdc73ac11e3dc4df02a83a4e721297aa0756acb6"
    }
  }
]